Rahoto kan sakamakon kudi na kamfanin Syros Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Syros Pharmaceuticals, Inc. buga rahotanni na kudi?
Syros Pharmaceuticals, Inc. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a US dollar a yau
Kudin shiga yanar gizo Syros Pharmaceuticals, Inc. - -14 228 000 $. Ana amfani da bayani game da kudin shiga na yanar gizo daga hanyoyin budewa. Thearfin kuɗin shiga na Syros Pharmaceuticals, Inc. ya canza ta 15 902 000 $ a cikin 'yan shekarun nan. Waɗannan su ne manyan alamu na Syros Pharmaceuticals, Inc.. Jadawalin rahoton hadahadar kudi na Syros Pharmaceuticals, Inc. na yau. Shafin rahoton hada-hadar kudade a shafin yanar gizonmu yana nuna bayanan ta hanyar kwanakin da 30/06/2018 to 31/03/2021. Darajar "jimlar kudaden shiga ta Syros Pharmaceuticals, Inc." akan wannan hoton an yiwa alama mai launin shuɗi.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
31/03/2021
4 827 000 $
+963.22 % ↑
-14 228 000 $
-
31/12/2020
5 699 000 $
+538.19 % ↑
-30 130 000 $
-
30/09/2020
3 828 000 $
+586.02 % ↑
-19 486 000 $
-
30/06/2020
3 188 000 $
+590.04 % ↑
-17 196 000 $
-
30/09/2019
558 000 $
-
-19 793 000 $
-
30/06/2019
462 000 $
-
-19 455 000 $
-
31/03/2019
454 000 $
-
-16 461 000 $
-
31/12/2018
893 000 $
-
-18 032 000 $
-
30/09/2018
412 000 $
-
-15 737 000 $
-
30/06/2018
375 000 $
-
-14 047 000 $
-
Nuna:
To
Rahoton kudi Syros Pharmaceuticals, Inc., tsarawa
Zamanin sabbin bayanan kudi na Syros Pharmaceuticals, Inc.: 30/06/2018, 31/12/2020, 31/03/2021. Kwanan bayanan bayanan kuɗi ana ƙaddara su ta hanyar dokokin lissafi. Sabuwar kwanan rahoton rahoton kudi na Syros Pharmaceuticals, Inc. shine 31/03/2021. Babban riba Syros Pharmaceuticals, Inc. shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa. Babban riba Syros Pharmaceuticals, Inc. ne 4 827 000 $
Dates na kudi rahotanni Syros Pharmaceuticals, Inc.
Ribar kuɗi Syros Pharmaceuticals, Inc. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Syros Pharmaceuticals, Inc. ne -14 228 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
4 827 000 $
5 699 000 $
3 828 000 $
3 188 000 $
558 000 $
462 000 $
454 000 $
893 000 $
412 000 $
375 000 $
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
-
-
-
-
-
-
-
-
-
-
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
4 827 000 $
5 699 000 $
3 828 000 $
3 188 000 $
558 000 $
462 000 $
454 000 $
893 000 $
412 000 $
375 000 $
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
558 000 $
462 000 $
454 000 $
893 000 $
412 000 $
375 000 $
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-20 941 000 $
-29 219 000 $
-18 997 000 $
-16 741 000 $
-20 389 000 $
-20 208 000 $
-16 973 000 $
-18 607 000 $
-16 320 000 $
-14 548 000 $
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
-14 228 000 $
-30 130 000 $
-19 486 000 $
-17 196 000 $
-19 793 000 $
-19 455 000 $
-16 461 000 $
-18 032 000 $
-15 737 000 $
-14 047 000 $
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
20 029 000 $
29 026 000 $
17 674 000 $
14 796 000 $
15 931 000 $
15 475 000 $
12 562 000 $
15 128 000 $
12 856 000 $
11 082 000 $
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
25 768 000 $
34 918 000 $
22 825 000 $
19 929 000 $
20 947 000 $
20 670 000 $
17 427 000 $
19 500 000 $
16 732 000 $
14 923 000 $
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
226 677 000 $
178 557 000 $
98 563 000 $
112 451 000 $
111 020 000 $
124 368 000 $
77 763 000 $
101 734 000 $
115 544 000 $
126 951 000 $
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
260 627 000 $
213 250 000 $
133 335 000 $
147 816 000 $
143 831 000 $
151 827 000 $
88 428 000 $
106 766 000 $
120 634 000 $
131 379 000 $
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
222 142 000 $
173 984 000 $
93 133 000 $
108 674 000 $
33 364 000 $
101 740 000 $
22 129 000 $
49 886 000 $
43 524 000 $
114 386 000 $
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
-
-
-
-
22 570 000 $
15 332 000 $
14 979 000 $
19 529 000 $
21 297 000 $
17 679 000 $
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
-
-
-
-
-
-
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
-
-
-
-
49 257 000 $
39 912 000 $
24 410 000 $
28 180 000 $
25 797 000 $
22 667 000 $
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
-
-
-
-
34.25 %
26.29 %
27.60 %
26.39 %
21.38 %
17.25 %
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
149 880 000 $
90 553 000 $
45 940 000 $
62 406 000 $
94 574 000 $
111 915 000 $
64 018 000 $
78 586 000 $
94 837 000 $
108 712 000 $
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-
-
-
-
-11 224 000 $
-18 099 000 $
-20 327 000 $
-13 812 000 $
-10 025 000 $
-14 078 000 $
Rahoton kudi na baya-bayan nan game da kudin shiga na Syros Pharmaceuticals, Inc. shine ranar 31/03/2021. A cewar sabon rahoto game da sakamakon kudi na Syros Pharmaceuticals, Inc., yawan kudaden da Syros Pharmaceuticals, Inc. ya samu ya kai 4 827 000 US dollar kuma ya canza zuwa +963.22% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Syros Pharmaceuticals, Inc. a cikin kwata na karshe shine -14 228 000 $, karuwar riba ta karu da 0% idan aka kwatanta da bara.
Kudin hannun jari Syros Pharmaceuticals, Inc.
Kudin hannun jari Syros Pharmaceuticals, Inc.
Sharorin Syros Pharmaceuticals, Inc. a yau, farashin kayayyaki SYRS yana da layi yanzu.
Rahoto kan sakamakon kudi na kamfanin Syros Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024.
